Details Storage: Store in a cool, dry place away from direct sunlight
Full catalog
Common side effects include: Injection site reactions mild pain, redness, swelling, or bruising at the injection site, typically resolving within a few days Headache usually transient and manageable with standard analgesia Nausea or dizziness particularly in the initial treatment phase Skin reactions including itching, mild rash, or acneiform eruptions Temporary urine discolouration red or orange urine is harmless and expected Diarrhoea or flushing usually mild and self-limiting In patients with severe megaloblastic anaemia, low potassium levels (hypokalaemia) may occur during initial intensive treatment, but this is uncommon in routine maintenance therapy
There's a slight risk of developing acne or skin rashes in some people, particularly at higher doses
No, BPC-157 is not FDA-approved
For systemic effects, the abdomen is standard